BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2009
View Archived Issues
Boehringer Ingelheim describes Factor Xa inhibitors for the treatment of thrombotic disorders
Read More
Nuvo and Covidien sign U.S. agreement for Pennsaid and Pennsaid Plus
Read More
Novel 11beta-HSD1and sEH inhibitors presented by GlaxoSmithKline for cardiovascular conditions
Read More
AstraZeneca and Dainippon Sumitomo Pharma describe novel TLR receptor modulators
Read More
Piclozotan shows preclinical and clinical efficacy in improving PD motor complications
Read More
Pennsylvania State University presents D1 dopamine agonist with antiparkinson potential
Read More
Phase IIb analyses further delineate linaclotide activity in chronic and IBS-constipation
Read More
ExonHit completes patient dosing in phase II clinical trial of EHT-0202 in AD
Read More
Abbott initiates enrollment into SPIRIT PRIME trial of Xience Prime coronary stent
Read More
CeNeRx completes USD 9 million financing and acquires rights to CXB-909 from Krenitsky
Read More
Idera presents update on drug candidate pipeline targeted to toll-like receptors
Read More
Roche describes novel FBPase inhibitors as antidiabetics
Read More
Teduglutide substudy shows effects on intestinal absorption in short bowel syndrome
Read More
Multiple studies of AZD-3355 presented at Digestive Disease Week
Read More
Autologous cancer vaccine TAG prolongs stable disease in phase I trial in advanced cancer patients
Read More
Akela and Teikoku amend license and codevelopment agreement for Fentanyl Taifun
Read More
Safety committee recommends continuation of BioSante's phase III study of LibiGel in HSDD
Read More
FDA grants fast track designation to Epeius' Rexin-G for treatment of pancreatic cancer
Read More
Ligand commences clinical trial with selective androgen receptor modulator LGD-4033
Read More
Antigenics' QS-21 adjuvant used in pivotal phase III malaria vaccine trial
Read More
Phase II trial shows elacytarabine may increase survival in late-stage leukemia
Read More
Neuromed sells U.S. rights to Exalgo to Mallinckrodt
Read More
COMP grants orphan drug designation to Clinuvel's afamelanotide for solar urticaria
Read More
FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS
Read More
Watson enters agreement to acquire Arrow Group
Read More